Galera Therapeutics, Inc. (GRTX) Debt-to-equity % [USD] 2020 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Galera Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2020 to 2024.
  • Galera Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was -126 %, a 19% increase year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 -126 +29.6 +19% Mar 31, 2024
Q4 2023 -137 +26.4 +16.2% Dec 31, 2023
Q3 2023 -142 +43.8 +23.5% Sep 30, 2023
Q2 2023 -148 +74.9 +33.6% Jun 30, 2023
Q1 2023 -156 +131 +45.8% Mar 31, 2023
Q4 2022 -163 +205 +55.7% Dec 31, 2022
Q3 2022 -186 +418 +69.2% Sep 30, 2022
Q2 2022 -223 +6.85 K +96.8% Jun 30, 2022
Q1 2022 -287 -794 -157% Mar 31, 2022
Q4 2021 -368 -612 -251% Dec 31, 2021
Q3 2021 -604 -753 -506% Sep 30, 2021
Q2 2021 -7.07 K -8.48 K -601% Jun 30, 2021
Q1 2021 507 Mar 31, 2021
Q4 2020 244 Dec 31, 2020
Q3 2020 149 Sep 30, 2020
Q2 2020 1.41 K Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.